2022
DOI: 10.1186/s12951-022-01552-0
|View full text |Cite
|
Sign up to set email alerts
|

Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system

Abstract: Despite explosive growth in the development of nano-drug delivery systems (NDDS) targeting tumors in the last few decades, clinical translation rates are low owing to the lack of efficient models for evaluating and predicting responses. Microfluidics-based tumor-on-a-chip (TOC) systems provide a promising approach to address these challenges. The integrated engineered platforms can recapitulate complex in vivo tumor features at a microscale level, such as the tumor microenvironment, three-dimensional tissue st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 115 publications
0
19
0
Order By: Relevance
“…Ideally, in vivo effects should be predicted by in vitro experiments: thus, we aimed to establish a system which enabled the investigation of the anti-tumor efficacy of magnetically accumulated particles or immune cells against spheroids. Hitherto, others had performed investigations on tumor spheroids with nanoparticles under flow conditions, but without magnetic fields [ 49 , 50 ]. We had already performed a pilot study employing colon carcinoma spheroids placed in hand-made agarose beds in Ibidi µ-slides [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Ideally, in vivo effects should be predicted by in vitro experiments: thus, we aimed to establish a system which enabled the investigation of the anti-tumor efficacy of magnetically accumulated particles or immune cells against spheroids. Hitherto, others had performed investigations on tumor spheroids with nanoparticles under flow conditions, but without magnetic fields [ 49 , 50 ]. We had already performed a pilot study employing colon carcinoma spheroids placed in hand-made agarose beds in Ibidi µ-slides [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Third, significant differences exist between animal models and humans [107,108], and further research on the correlations between them is required. Advances in technology such as organ-on-a-chip or organoids may be promising for evaluating these complicated synergistic strategies [109][110][111]. In addition, most studies have focused on the combined influence of PDT and ferroptosis on intracellular redox homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…[ 108 ] Microfluidics‐based tumor‐on‐a‐chip systems can replicate advanced in vivo tumor features at a microscale level, such as the tumor microenvironment, 3D tissue structure, and dynamic culture conditions, improving the correlation between preclinical and clinical trial results in evaluating chemotherapeutic nanomedicines. [ 109 ] Meanwhile, the use of magnetic nanoparticle‐based microfluidic chips in conjunction with established procedures allows for rapid, efficient, and early diagnostic resolution in lung cancer. [ 110 ]…”
Section: Application Of Mixing For the Precipitation Of Apismentioning
confidence: 99%